Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Serologic Response to SARS-COV-2 / Coronavirus Disease 2019 (COVID-19) in Children, Adolescents, and Young Adults Receiving Biologic Therapies (RECONN)

NCT04838834 is registered in ClinicalTrials.gov with Connecticut Children's Medical Center as lead sponsor.

NCT NCT04838834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04838834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Serologic Response to SARS-COV-2 / Coronavirus Disease 2019 (COVID-19) in Children, Adolescents, and Young Adults Receiving Biologic Therapies (RECONN)
Lead sponsor
Connecticut Children's Medical Center
Phase
Observational
Overall status
Completed
Start date
May 15, 2020
Completion date
February 10, 2025
Enrollment
472 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, inflammatory bowel diseases, sars-cov-2